New York orthopedic billing services are operating under a fundamentally different revenue environment in 2026 — and most practices haven’t caught up to it yet. The CY 2026 Physician Fee Schedule Final Rule (CMS-1832-F) applied a −2.5% efficiency adjustment to orthopedic surgical work RVUs, compressing base reimbursement on the same procedures your surgeons performed last year.
The Transforming Episode Accountability Model (TEAM), active through December 31, 2030, holds 741 acute care hospitals across the country financially accountable for the full 30-day episode of care following high-cost orthopedic surgery. And CMS-0057-F now mandates prior authorization decisions within 72 hours for urgent requests — accelerating denials just as fast as approvals.
For multi-surgeon orthopedic groups in New York, this isn’t an administrative inconvenience. It’s a margin compression event. The only way to protect profitability in this environment is to operate with billing infrastructure built specifically for orthopedic complexity.
The Triple Threat to New York Orthopedic Margins
Before talking about solutions, let’s name what’s actually draining revenue from orthopedic practices across New York right now.
1. Implant Revenue Leakage ($180K–$240K annually per practice)
Orthopedic surgery is implant-intensive. Total joint replacements, spinal fusions, and arthroscopic procedures with biologics all carry high-dollar HCPCS L-code charges that must be captured at point of service — not reconciled days later from a paper OR log.
Our analysis of 73 multi-surgeon practices found that 67% lack real-time OR system integration, resulting in an average $240K annually in unbilled or miscoded implant charges.
In New York’s high-volume surgical markets — from Manhattan’s Hospital for Special Surgery corridor to Buffalo’s orthopedic group practices — that leakage compounds every billing cycle it goes unaddressed.
2. Global Period Documentation Gaps
CMS’s strict interpretation of global surgical packages under the 2026 PFS has narrowed what qualifies as separately billable during pre- and post-operative periods. Routine follow-up visits billed during a 90-day global period without modifier 24 (unrelated E/M) or modifier 79 (unrelated procedure) generate automatic denials.
CPT 99024 reporting for post-op visits is now under active MAC audit scrutiny — Novitas, the Medicare Administrative Contractor for New York, cross-matches date-of-service claims against surgical records to identify global period billing inconsistencies. Practices that don’t have embedded global period modifier protocols in their billing workflow are funding those denials invisibly.
3. ICD-10 Seventh-Character Specificity
This one is more recent and catches more practices off guard than it should. Payers — including New York’s dominant commercial carriers — now enforce ICD-10 coding to the seventh character level on surgical claims.
Submitting M17.9 (knee osteoarthritis, unspecified) instead of M17.11 (primary osteoarthritis, right knee) triggers immediate medical necessity review or outright denial across Medicare Advantage and commercial plans.
With 47 new CPT codes introduced for robotic orthopedic procedures in 2026 (AMA CPT 2026 Updates), the coding complexity has increased dramatically — and generalist coders are generating denial rates 19 percentage points higher than orthopedic-certified specialists.
What MBC’s New York Orthopedic Billing Services Deliver
MBC operates a dedicated Orthopedic Center of Excellence with billers trained exclusively on orthopedic surgical coding, global period modifier protocols, implant charge capture, and New York payer-specific documentation requirements. Here’s how that translates operationally:
| Revenue Leakage Point | Generic RCM | MBC Orthopedic COE |
| Implant Capture | Manual log reconciliation | Real-time OR integration, same-day HCPCS filing |
| Global Period | Modifier applied inconsistently | Embedded 90-day protocol, CPT 99024 tracked |
| ICD-10 Specificity | Unspecified codes submitted | 7th character enforced before claim leaves queue |
| Prior Authorization | Submitted at scheduling; chased post-denial | Auth initiated with complete documentation packet |
| Payer Variance | Single workflow for all payers | Separate protocols for Medicare Advantage, Empire, United |
| NCR Benchmark | 85–89% average | 94–98% average within 90 days |
Multi-surgeon orthopedic groups working with MBC average a 16% improvement in Net Collection Ratio within the first 90 days — translating to $420K in additional annual revenue for a practice with $3M in surgical collections.
New York Orthopedic Markets We Serve
MBC provides orthopedic billing services across every major New York market. Whether your group operates in a dense Tri-State referral corridor or a regional hub upstate, we are actively managing orthopedic claims in these cities and surrounding areas:
New York City (Manhattan, Brooklyn, Queens, The Bronx, Staten Island) — Buffalo — Rochester — Yonkers — Syracuse — Albany — New Rochelle — Mount Vernon — Schenectady — Utica — White Plains — Hempstead — Brentwood — Valley Stream — Freeport — Long Island City — Poughkeepsie — Middletown — Spring Valley — Huntington — Amityville — Babylon — Commack — Hauppauge — Smithtown — Garden City — Great Neck — Port Chester — Niagara Falls — Troy
From HSS-affiliated multi-surgeon groups in Manhattan to regional orthopedic practices in Buffalo, Rochester, and the Hudson Valley — our billers are in your market.
Your 90-Day Orthopedic Revenue Diagnostic
Most New York orthopedic practices that engage MBC discover between $180K and $420K in recoverable revenue in the first audit.
We review your last 90 days of surgical claims against Novitas LCD requirements, identify implant charges that missed the billing cycle, flag global period denials that were written off instead of appealed, and calculate your actual NCR against the 95%+ benchmark for surgical orthopedic practices.
It costs nothing to find out exactly where your revenue is going.
Schedule Your Orthopedic Revenue Diagnostic
FAQs
New York orthopedic billing operates at the intersection of high-dollar implant coding, global surgical package compliance, Workers’ Comp and personal injury lien complexity, and one of the most aggressive commercial payer environments in the country. Empire BlueCross, United Healthcare Oxford, and Healthfirst each maintain distinct prior authorization criteria and documentation standards for joint replacement and spine procedures. Add Novitas MAC jurisdiction for Medicare claims and New York’s dense Medicare Advantage penetration rate — and the billing precision required to maintain a 95%+ NCR is categorically different from office-based specialties.
The CY 2026 Physician Fee Schedule Final Rule (CMS-1832-F) applied a −2.5% efficiency adjustment to surgical work RVUs. For New York orthopedic practices, this means the same total joint replacement, spinal fusion, or arthroscopic procedure generates measurably less Medicare revenue in 2026 than it did in 2025. Geographic RVU adjustments partially offset this in high-cost NYC markets, but the net effect across New York is a direct margin compression — making implant capture and global period compliance more financially consequential than ever.
MBC serves orthopedic practices across all of New York — from the five boroughs of New York City and Long Island markets including Hempstead, Huntington, and Garden City, to upstate hubs including Buffalo, Rochester, Albany, Syracuse, and Utica, and Hudson Valley and Westchester markets including White Plains, Yonkers, Poughkeepsie, and New Rochelle.
Our orthopedic coders manage the full surgical spectrum — total joint replacements (CPT 27130, 27447), multi-level spinal fusions (CPT 22100–22899), arthroscopic procedures including CPT 29881 (knee meniscectomy) and 29827 (shoulder rotator cuff repair), fracture care with correct global period designations, E/M visit coding under MDM-based selection, and the 47 new robotic procedure codes introduced in AMA CPT 2026. We also manage modifier 24, 25, 51, 59, and 79 application across all New York payer contracts.
Our 90-Day Revenue Diagnostic typically surfaces the highest-value leakage points within the first two weeks — implant charges that fell off the billing cycle, global period denials that aged into write-offs, and ICD-10 specificity errors generating medical necessity rejections. Most New York orthopedic practices discover $180K–$420K in recoverable revenue in the first audit, with measurable NCR improvement visible within the first 60–90 days of engagement.
New York Orthopedic Billing Services: Maximize Profit
Phone: 888-357-3226Email: sales@medicalbillersandcoders.com
